Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Algernon’s business model is based on drug re-purposing, finding new uses for know drugs





 

Bullboard - Investor Discussion Forum Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc > New video (Streamed an hour ago)
View:
Post by DigitalSpurs on Apr 14, 2020 4:03pm

New video (Streamed an hour ago)

New Video out!

Featured on the front page. Great reduction in scarring and outperformed two major players in the game.


Streamed one hour ago. Useful listen!

https://midasletter.com/2020/04/ifenprodil-the-specialized-drug-treating-coronavirus/
Comment by DigitalSpurs on Apr 14, 2020 4:09pm
I love the fact that the CEO is very active; going out, doing interviews, representing the company and shareholders, while the scientists do their job to get things to the next level. Really good feeling about this company! Well spoken, brief and lots of evidence.   Never goes overboard with promises to be number one, but states that they did outperform some leaders in the pharma space ...more  
Comment by grosdavid on Apr 14, 2020 4:20pm
I think the solid point here is : preclinical trials have already been done here. Many Bio are at this stage right now. AGN, if it is able to prove what it thinks ifenprodil can do, they can run up to a human trial QUICKLY. Thanks for the share.    
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

Connect with C.AGN


CEO Clips: DMT Clinical Trial

CEO Q&A Interview with Chris Moreau

Investor Presentation

Download the latest Investor Presentaion

Algernon Highlights: The Watchlist

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Investment Opportunity

The Algernon Value Proposition



  • Advancing new drug treatments for billion dollar global disease markets.
  • Re-purposed compounds have a much lower risk of failing in human trials as a result of safety issues.
  • Conducting multiple phase II clinical trials.
  • Highly capital efficient business model.
  • Experienced management team & globally recognized medical advisory board.

Facebook